Fishing Amazon is a sport fishing tourism operator offering guided fishing expeditions in the Brazilian Amazon. The company provides all-inclusive packages including professional guides, fully equipped boats, lodge accommodation, meals, and transportation. It specializes in trophy freshwater fishing experiences for international anglers.
Fipan Brazil
FIPAN is one of the largest and most influential trade fairs for the bakery, confectionery, and foodservice industries in Latin America. Held annually in July at Expo Center Norte in São Paulo, Brazil, the event consistently attracts over 59,000 professionals—including bakery owners, pastry chefs, café managers, pizzeria operators, and equipment suppliers—from across Brazil and the world. A key event for those looking to do business in Latin America. The next edition will be held from July 21 to 24, 2026. Book your participation as soon as possible.
FAPESP
Priveate foundation for research supported by the State of Sao Paulo
Cytiva
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery. We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more. | Diagnostic assays like the ones you’re developing are in demand. Set yourself up for success by choosing a supplier that delivers quality products for your entire workflow and offers specialized services and capabilities needed to commercialize your assays. Using a single supplier for multiple components, from membranes to magnetic beads, can streamline your development process and ultimately accelerate the commercialization of diagnostic assays and kits. Cytiva can help you speed up and scale up without staffing up! With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical knowledge and talent, a broad and deep portfolio, and exceptional service to support biotechs at every stage from discovery to delivery. Visit cytiva.com/diagnostics to learn more. | Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics – from discovery to delivery. Together, as Cytiva, we supply the tools and support our customers need to work better, faster and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. | Cytiva is a global life sciences leader that works with academic and translational researchers, developers and manufacturers of biotherapeutics, cell and gene therapies, and new technologies such as mRNA, to enable the delivery of transformative medicines. Cytiva is a trusted expert with nearly 10 000 associates in 43 countries dedicated to customers’ speed, flexibility, capacity and efficiency in drug discovery, research, and manufacturing.
Cor.Sync
Cor.Sync is a solution for fast and accurate heart attack diagnosis at the hospital emergency care. Myocardial infarction, also known as heart attack, is one of the biggest causes of death around the world. But its diagnosis requires, along with electrocardiogram, a blood test to measure a biomarker, called troponin. Nowadays it takes from 1 to 5 hours to measure troponin at laboratories, and half of the deaths by infarction happens inside hospital, while the patient is waiting for these results. Cor.Sync is a point of care testing platform, with a desktop device and biosensors, capable of measuring troponin in just 8 minutes with the same accuracy and price as a laboratory test.
Commpazz International
Founded in 2013, COMMPAZZ has emerged to supply the absence of export, import and communication services in the pet market. In order to develop these services, we believe that the professionalization and qualification of the sector was essential to reach new markets. Our company innovates bringing a concept of intelligent, personalized and affordable solutions. We carry out everything from structuring the company’s export department to tracking the product in the target market. We believe that our expertise, coupled with a new way of delivering results, contributes to the development of the international pet market.
Celluris
Celluris is the first Latin American company developing personalized treatment for cancer patients through CAR-T immunotherapy for Solid Tumors. This technique is based on the modification of the patient’s cells into recognizing the tumor as a target, fighting it accurately. Celluris’ novel solution, RfuCAR, was engineering to respond to some challenges in the field. RfuCAR is a bispecific receptor CAR, composed by an antigen binding domain and another domain that binds to an extracellular molecule from tumoral microenvironment. Therefore, RfuCAR can modulate the tumoral microenvironment by trapping an extracellular molecule, reducing inhibitory signaling and improving the CAR anti-tumoral function. In addition, our platform encompasses a switch on/off/modulation system to control toxicity, so with administration of small peptides that will block CAR epitopes, it will be possible to minimize the effects of CRS and neurotoxicity, very common in patients treated with CAR-T therapy. Our first targets will be lung, pancreatic and mesothelioma tumors, we already obtained some encouraging in vitro data, showing almost 30% of tumoral epithelial cells killing. With P&D located in São Paulo, Brazil, and with office in US, Celluris was co-founded by Yechiel Stern and Patricia Rozenchan.